Tower Research Capital (TRC)’s Immunovant IMVT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$370K	Buy	14,905 +11,353	+320%	+$294K	0.01%	1142
2025 Q4	$90.3K	Sell	3,552 -2,964	-45%	-$66.1K	﹤0.01%	2007
2025 Q3	$105K	Buy	6,516 +376	+6%	+$6.09K	﹤0.01%	1949
2025 Q2	$98.2K	Buy	6,140 +4,273	+229%	+$64.6K	﹤0.01%	2391
2025 Q1	$31.9K	Sell	1,867 -14,375	-89%	-$301K	﹤0.01%	2565
2024 Q4	$402K	Buy	16,242 +15,226	+1,499%	+$432K	0.01%	1216
2024 Q3	$29K	Sell	1,016 -13,126	-93%	-$387K	﹤0.01%	3021
2024 Q2	$373K	Buy	14,142 +13,630	+2,662%	+$388K	0.01%	1584
2024 Q1	$16.5K	Sell	512 -6,863	-93%	-$250K	﹤0.01%	3172
2023 Q4	$311K	Sell	7,375 -2,253	-23%	-$82.9K	﹤0.01%	1751
2023 Q3	$370K	Buy	9,628 +7,852	+442%	+$177K	0.01%	1052
2023 Q2	$33.7K	Sell	1,776 -19,025	-91%	-$355K	﹤0.01%	2918
2023 Q1	$322K	Buy	20,801 +17,554	+541%	+$305K	0.01%	1097
2022 Q4	$58K	Sell	3,247 -8,436	-72%	-$106K	﹤0.01%	2238
2022 Q3	$65K	Buy	11,683 +5,923	+103%	+$29K	﹤0.01%	2923
2022 Q2	$22K	Sell	5,760 -4,670	-45%	-$20.2K	﹤0.01%	3694
2022 Q1	$57K	Buy	10,430 +2,492	+31%	+$15.5K	﹤0.01%	2626
2021 Q4	$67K	Sell	7,938 -2,349	-23%	-$19.4K	﹤0.01%	2527
2021 Q3	$89K	Buy	10,287 +6,200	+152%	+$55.9K	﹤0.01%	2499
2021 Q2	$43K	Sell	4,087 -1,659	-29%	-$23.2K	﹤0.01%	3145
2021 Q1	$92K	Buy	5,746 +3,296	+135%	+$86.9K	﹤0.01%	2649
2020 Q4	$113K	Sell	2,450 -1,496	-38%	-$69.2K	﹤0.01%	2226
2020 Q3	$139K	Buy	3,946 +2,891	+274%	+$87K	﹤0.01%	2887
2020 Q2	$26K	Buy	+1,055	New	+$22.6K	﹤0.01%	3536